Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
18.29
-0.20 (-1.08%)
Oct 1, 2026, 3:12 PM EDT - Market open
Sotera Health Company Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,220 | 5,011 | 3,875 | 4,762 | 2,350 | 6,663 | |
Market Cap Growth | 16.67% | 29.34% | -18.64% | 102.65% | -64.73% | -14.60% |
Enterprise Value | 7,131 | 6,992 | 5,925 | 6,843 | 4,018 | 8,374 |
Last Close Price | 18.49 | 17.64 | 13.68 | 16.85 | 8.33 | 23.55 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 32.60 | 64.29 | 87.39 | 93.21 | - | 57.76 |
Forward PE | 18.05 | 19.12 | 18.03 | 18.81 | 8.38 | 24.18 |
PS Ratio | 4.29 | 4.31 | 3.52 | 4.54 | 2.34 | 7.15 |
PB Ratio | 7.93 | 8.27 | 9.57 | 10.73 | 6.71 | 11.37 |
P/FCF Ratio | 46.29 | 33.59 | 85.93 | - | 24.59 | 37.14 |
P/OCF Ratio | 17.85 | 17.45 | 17.29 | - | 8.45 | 23.67 |
PEG Ratio | - | 1.37 | 1.50 | 0.79 | 0.47 | 1.34 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.86 | 6.01 | 5.38 | 6.52 | 4.00 | 8.99 |
EV/EBITDA Ratio | 12.36 | 12.64 | 11.81 | 14.04 | 8.45 | 18.26 |
EV/EBIT Ratio | 15.88 | 16.87 | 17.66 | 20.93 | 12.26 | 27.41 |
EV/FCF Ratio | 63.24 | 46.87 | 131.39 | - | 42.04 | 46.68 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 3.41 | 3.76 | 5.81 | 5.24 | 5.80 | 3.12 |
Debt / EBITDA Ratio | 3.85 | 4.02 | 4.56 | 4.64 | 4.14 | 3.86 |
Debt / FCF Ratio | 20.13 | 15.26 | 52.13 | - | 21.26 | 10.19 |
Net Debt / Equity Ratio | 2.87 | 3.19 | 5.12 | 4.58 | 4.67 | 2.94 |
Net Debt / EBITDA Ratio | 3.32 | 3.49 | 4.13 | 4.17 | 3.44 | 3.75 |
Net Debt / FCF Ratio | 16.96 | 12.95 | 45.96 | -5.60 | 17.12 | 9.59 |
Asset Turnover | 0.37 | 0.37 | 0.36 | 0.34 | 0.34 | 0.34 |
Inventory Turnover | 8.63 | 9.21 | 9.47 | 10.18 | 9.07 | 8.74 |
Quick Ratio | 2.40 | 2.09 | 2.32 | 2.05 | 0.70 | 1.50 |
Current Ratio | 2.80 | 2.46 | 2.75 | 2.42 | 0.82 | 2.15 |
Return on Equity (ROE) | 27.78% | 15.42% | 10.46% | 12.94% | -49.89% | 22.22% |
Return on Assets (ROA) | 8.60% | 8.18% | 6.76% | 6.54% | 6.94% | 6.88% |
Return on Invested Capital (ROIC) | 10.78% | 8.73% | 5.28% | 7.11% | 15.28% | 8.89% |
Return on Capital Employed (ROCE) | 14.60% | 13.70% | 11.60% | 11.30% | 14.10% | 11.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.13% | 1.55% | 1.15% | 1.08% | -9.94% | 1.75% |
FCF Yield | 2.16% | 2.98% | 1.16% | -7.62% | 4.07% | 2.69% |
Buyback Yield / Dilution | -1.35% | -0.53% | -0.60% | -1.12% | -0.26% | -17.54% |